Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025Dosing ...

Design has initiated dosing in a Phase 1 clinical trial in healthy volunteers in Australia to evaluate the safety and ...

Design Therapeutics, Inc. announced the initiation of a Phase 1 clinical trial for its gene-targeted treatment DT-216P2 in healthy volunteers, with patient dosing for Friedreich Ataxia (FA ...

Six teams of children from schools around the country tackle some difficult design challenges, with help from three talented young engineers. How to design and make a moving shop window display.

A young entrepreneur is shown how to create and design his own company logo. Different company logo styles are looked at – shapes, use of text and symbols as well as bold, bright colours can all ...